Meridian Medcl Drug Patent Portfolio
Meridian Medcl owns 1 orange book drug protected by 1 US patent Given below is the list of Meridian Medcl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7811254 | Autoinjector with needle depth adapter | 26 Aug, 2027 | Active |
Latest Legal Activities on Meridian Medcl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Meridian Medcl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Oct, 2022 | US7811254 |
| 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity | 12 Oct, 2022 | US7811254 |
|
Maintenance Fee Reminder Mailed
Critical
| 30 May, 2022 | US7811254 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Mar, 2018 | US7811254 |
|
Email Notification
Critical
| 10 Jun, 2016 | US7811254 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 10 Jun, 2016 | US7811254 |
|
Correspondence Address Change
Critical
| 09 Jun, 2016 | US7811254 |
|
Correspondence Address Change
Critical
| 29 Aug, 2014 | US7811254 |
| Post Issue Communication - Certificate of Correction | 03 Nov, 2010 | US7811254 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Oct, 2010 | US7811254 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Oct, 2010 | US7811254 |
|
Email Notification
Critical
| 23 Sep, 2010 | US7811254 |
|
Issue Notification Mailed
Critical
| 22 Sep, 2010 | US7811254 |
| Dispatch to FDC | 02 Sep, 2010 | US7811254 |
|
Email Notification
Critical
| 31 Aug, 2010 | US7811254 |
Meridian Medcl's Family Patents
Meridian Medcl drugs have patent protection in a total of 4 countries. It has a significant patent presence in the US with 57.1% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Meridian Medcl Drug List
Given below is the complete list of Meridian Medcl's drugs and the patents protecting them.
1. Alsuma
Alsuma is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7811254 | Autoinjector with needle depth adapter |
26 Aug, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alsuma's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List